These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2878701)

  • 1. A case of resistant schizophrenia.
    Roberts JE; Edwards JG; Checkley S; Crammer JL; Cutting JC; Lader MH; Murray RM
    Br J Psychiatry; 1986 Dec; 149():789-93. PubMed ID: 2878701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K; Mrowiec W
    Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome--a case report].
    Lanczik M; Fritze J
    Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between procyclidine and neuroleptic drugs. Some pharmacological and clinical aspects.
    Bamrah JS; Kumar V; Krska J; Soni SD
    Br J Psychiatry; 1986 Dec; 149():726-33. PubMed ID: 2878700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
    Portier A; Sarfati Y
    Encephale; 2000; 26(4):75-7. PubMed ID: 11064844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine and tardive dyskinesia.
    Miller DD
    Am J Psychiatry; 2003 Mar; 160(3):588. PubMed ID: 12611849
    [No Abstract]   [Full Text] [Related]  

  • 10. Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study.
    Ortiz BB; Araújo Filho GM; Araripe Neto AG; Medeiros D; Bressan RA
    Braz J Psychiatry; 2013; 35(4):432-4. PubMed ID: 24402218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared decision making in schizophrenia treatment.
    Preda A
    J Clin Psychiatry; 2008 Feb; 69(2):326; author reply 326-7. PubMed ID: 18363459
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
    Bechter K
    Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia.
    Brizer DA; Hartman N; Sweeney J; Millman RB
    Am J Psychiatry; 1985 Sep; 142(9):1106-7. PubMed ID: 2862800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluphenazine decanoate vs oral antipsychotics: a comparison of their effectiveness in the treatment of schizophrenia as measured by a reduction in hospital readmissions.
    Devito RA; Brink L; Sloan C; Jolliff F
    J Clin Psychiatry; 1978 Jan; 39(1):26-34. PubMed ID: 24614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H
    Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Flexibility in the use of fluphenazine decanoate.
    Marriott P; Grigor J; Hiep A
    Br J Psychiatry; 1975 Feb; 126():204. PubMed ID: 1131475
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.